RBDCOV PROJECT
At Zabala Innovation, we're partners and we're in charge of management, communication, distribution and exploitation. So we've been tasked with promoting the initiative and coordinating and publishing the episodes
As part of its search for new dissemination formats, the project has been working on the production of a proprietary podcast called “RBDCOV Talks“. This audio format, which has seen remarkable growth in recent years, aims to broaden the public’s knowledge of various areas of medicine and science, including vaccine clinical trials.
The RBDCOV project, which has been running for almost two years, has focused on the development of HIPRA’s BIMERVAX® vaccine against COVID-19, supported by funding from the European Union as part of the Horizon Europe programme.
Comprising ten episodes, each featuring clinical research teams, healthcare professionals and community advocates, RBDCOV Talks is an integral part of Zabala Innovation’s communication and awareness-raising strategy.
Its main objective is to facilitate access to technical knowledge for non-specialist audiences. At the same time, “RBDCOV Talks” aims to keep the scientific community informed of the progress and results of ongoing clinical trials evaluating the efficacy, tolerance and safety of HIPRA’s BIMERVAX® recombinant vaccine.
The creation of this podcast is the result of a collaboration between members of the project consortium, resulting in a series of ten episodes of approximately 10 minutes each.
The podcast features researchers, scientists, clinicians, other health professionals and community advocates from five different European countries who have been active at different stages of the RBDCOV project.
The episodes cover a wide range of fascinating topics, from fundamental concepts of clinical research, such as the definition and nature of a vaccine clinical trial, to more complex issues, such as inclusion criteria and immunological memory.
Each episode of the podcast looks at relevant aspects of clinical vaccine research, providing detailed but accessible information. Interviewees include leading professionals such as Antonio Barreiro, Principal Investigator of the HIPRA Human Health Project, Pere Soler, Head of the Paediatric Infectious Diseases Unit at the Infectious Diseases Research Institute, head of the Paediatric Infectious Pathology and Immunodeficiency Unit at the Vall d’Hebron University Hospital and of the “Infection and Immunity in Paediatric Patients” group at the Vall d’Hebron Research Institute (VHIR), Pablo Rojo, Helena Belinchón, Montse Barceló, Juanfran Cabrera, Arda Karapinar, Julia García-Prado, Mete Tan, Antoni Castro and Laura Sesma.
The ten episodes of “RBDCOV Talks” are now available in English on the three main podcast distribution platforms: Spotify, Ivoox and Apple Podcasts.
News
RBDCOV PROJECT
Horizon Europe is funding the initiative, which has a budget of 9 million euros and will be implemented over two and a half years
Opinion
European projects
Javier Uranga
Entrepreneurship Consultant
Publication
FROM 'Z' TO 'A'
Because innovation means turning things upside down, our dictionary goes from Z to A, rather than A to Z
We provide advice to activities that encourage innovation, aimed at promoting the development of new innovative markets from the demand side, through public procurement.
We collaborate with public administrations to promote innovation and assist companies in integrating innovation into their overall strategy.
We are experts in European funding programmes, which provide the opportunity to finance the development and market access of your company's innovative projects.